Literature DB >> 8102159

Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.

J E Merrill1, L J Ignarro, M P Sherman, J Melinek, T E Lane.   

Abstract

Rat ameboid microglia are able to lyse rat oligodendrocytes in vitro. The lysis is inhibited by transforming growth factor-beta, antagonists of nitric oxide (NO) production, as well as antibodies to TNF-alpha, intercellular adhesion molecule-1 (ICAM-1), and leukocyte functional Ag-1. Ameboid microglial cells spontaneously produce detectable levels of the NO metabolite nitrite (NO2-). Stimuli such as PMA, LPS, and/or IFN-gamma induce micromolar concentrations of NO2- within 24 h. TNF-alpha increases IFN gamma but not LPS-induced NO2- production. Incubation with target oligodendrocytes also increases NO2- production in a contact-dependent manner. NO2- production is inhibited by NO synthase antagonists, transforming growth factor-beta, and anti TNF-alpha. Neither antileukocyte functional Ag-1 nor anti-ICAM-1 inhibit NO2- production by microglia in the presence or absence of oligodendrocytes. Indeed, anti-ICAM-1 treatment increases NO2- production. There is a correlation between ameboid microglial cell killing of oligodendrocytes and NO2- production suggesting NO may be a mechanism of death of the oligodendrocyte and possibly play a role in lesion formation in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102159

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  153 in total

Review 1.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

2.  The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia.

Authors:  L A Pasquini; C A Calatayud; A L Bertone Uña; V Millet; J M Pasquini; E F Soto
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

3.  Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.

Authors:  Asgar Zaheer; Shailendra K Sahu; Yanghong Wu; Ashna Zaheer; Joel Haas; Kiwhoon Lee; Baoli Yang
Journal:  Brain Res       Date:  2007-01-27       Impact factor: 3.252

4.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.

Authors:  Paula Maña; David Liñares; Sue Fordham; Maria Staykova; David Willenborg
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 5.  Intrinsic regulation of brain inflammatory responses.

Authors:  Elena Galea; Michael T Heneka; Cinzia Dello Russo; Douglas L Feinstein
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

6.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Authors:  L Probert; K Akassoglou; M Pasparakis; G Kontogeorgos; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.

Authors:  Kalipada Pahan; Malabendu Jana; Xiaojuan Liu; Bradley S Taylor; Charles Wood; Susan M Fischer
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

8.  Myelin basic protein-primed T cells induce nitric oxide synthase in microglial cells. Implications for multiple sclerosis.

Authors:  Subhajit Dasgupta; Malabendu Jana; Xiaojuan Liu; Kalipada Pahan
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

9.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

Authors:  George Bartzokis
Journal:  Adolesc Psychiatry       Date:  2005

10.  Microglia polarization by methylprednizolone acetate accelerates cuprizone induced demyelination.

Authors:  Golaleh Noorzehi; Parichehr Pasbakhsh; Maryam Borhani-Haghighi; Iraj Ragerdi Kashani; Soheila Madadi; Fatemeh Tahmasebi; Saied Nekoonam; Maryam Azizi
Journal:  J Mol Histol       Date:  2018-08-24       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.